FilingSEC EDGAR8-K
BioCardia Completes Revised FDA Pre-Submission for Helix Catheter Approval
· SEC accepted
StageRegulatory
Filing content
The company completed its revised pre-submission to the FDA under the Q-Submission program for the approval of its Helix Catheter.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…